SANOFI-AVENTIS - France 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:700-800
2019
Criterium:Position:
Overall Score:300-400
Total Number of Projects:200-300

Ranking timeline:

Project Participation Performance(2019-01-01 - 2021-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 26
As coordinator: 0
As participant: 26
Sole participant: 0
Coordinator / Participant Ratio: 0*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 79.422.753 0 6
2020 0 48.298.742 0 5
2019 0 214.067.873 0 15

Networking:

Partners:

Institution:Projects [No]:
NOVARTIS PHARMA18
PFIZER LIMITED18
JANSSEN PHARMACEUTICA NV13
F HOFFMANNLA ROCHE11
TAKEDA PHARMACEUTICALS INTERNATIONAL11
KATHOLIEKE UNIVERSITEIT LEUVEN10
ASTRAZENECA9
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD8
BAYER7
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE7
NOVO NORDISK7
UCB BIOPHARMA7
CHARITE UNIVERSITAETSMEDIZIN BERLIN6
ELI LILLY AND COMPANY LIMITED6
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT6
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE6
KING'S COLLEGE LONDON6
LEIDS UNIVERSITAIR MEDISCH CENTRUM6
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN6
TAKEDA DEVELOPMENT CENTRE EUROPE6
TEVA PHARMACEUTICAL INDUSTRIES LIMITED6
ABBVIE INC5
ACADEMISCH ZIEKENHUIS GRONINGEN5
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG5
LUND UNIVERSITY5
MERCK SHARP & DOHME CORP5
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU5
UNIVERSITAIR MEDISCH CENTRUM UTRECHT5
UNIVERSITY COLLEGE LONDON5
UNIVERSITY OF CAMBRIDGE5
UNIVERSITY OF DUNDEE5
UPPSALA UNIVERSITET5
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS4
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL4
ELI LILLY AND COMPANY4
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE4
FORUM DES PATIENTS EUROPEENS4
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA4
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE4
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS4
MEDIZINISCHE UNIVERSITAET WIEN4
STICHTING RADBOUD UNIVERSITEIT4
TEAM IT RESEARCH SL4
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA4
THE UNIVERSITY OF MANCHESTER4
UNIVERSITA VITASALUTE SAN RAFFAELE4
UNIVERSITE DU LUXEMBOURG4
UNIVERSITY OF NEWCASTLE UPON TYNE4
ACADEMIC MEDICAL CENTRE AMSTERDAM3
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS3
AUSTRIAN RESEARCH CENTERS SIEBERDORF3
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM3
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL3
CENTRE DE RECHERCHE PUBLIC DE LA SANTE3
CENTRE DE REGULACIO GENOMICA3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
GLAXOSMITHKLINE BIOLOGICALS3
GOETEBORGS UNIVERSITET3
JDRF INTERNATIONAL3
KAROLINSKA INSTITUTE3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN3
MEDIZINISCHE HOCHSCHULE HANNOVER3
STICHTING LYGATURE3
STICHTING VUMC3
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL3
THE UNIVERSITY OF SHEFFIELD3
UNIVERSITA DEGLI STUDI DI FERRARA3
UNIVERSITA DEGLI STUDI DI SIENA3
UNIVERSITAET ZUERICH3
UNIVERSITY COLLEGE DUBLIN3
UNIVERSITY OF COPENHAGEN3
UNIVERSITY OF EASTERN FINLAND3
UNIVERSITY OF OSLO3
ALLERGAN LIMITED2
ALZHEIMER EUROPE2
BRISTOLMYERS SQUIBB COMPANY CORP2
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY2
CENTRO DE INVESTIGACION BIOMEDICA EN RED2
COVANCE LABORATORIES2
DREEM2
DRESDEN UNIVERSITY OF TECHNOLOGY2
EATRIS ERIC2
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK2
EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING2
EUROPEAN FEDERATION OF CROHN'S AND ULCERATIVE COLITIS ASSOCIATIONS2
FUJIFILM CELLULAR DYNAMICS INC2
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT2
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES2
ISTITUTO SUPERIORE DI SANITA2
IXSCIENT LIMITED2
LONZA2
LYSOGENE2
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV2
MCROBERTS BV2
MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY2
MEDIZINISCHE UNIVERSITAT GRAZ2
MEDIZINISCHE UNIVERSITAT INNSBRUCK2
MEDTRONIC INTERNATIONAL TRADING SARL2
MIMETAS BV2

Constancy:

Total number of partners: 816
Partner loyalty:
Frequent Partner: (> 2 projects): 377
Rare Partner: 439
Frequent / Rare Partner Ratio: 0.86

Project overview:

Start dateProjectacronymrolefundingpartners
2021-11-01European platform for neurodegenerative disorders EPNDparticipant9.680.00029
2021-11-01Preparing for RSV Immunisation and Surveillance in Europe PROMISEparticipant3.744.37522
2021-10-01Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies SCREEN4CAREparticipant11.938.56935
2021-09-01Innovations to accelerate vaccine development and manufacture Inno4Vacparticipant18.600.00041
2021-07-01Real World Handling of Protein Drugs - Exploration, Evaluation and Education RealHOPEparticipant3.139.98425
2021-02-01Central Repository for Digital Pathology BIGPICTUREparticipant32.319.82548
2020-11-01Accelerating Research & Development for Advanced Therapies ARDATparticipant11.773.00034
2020-10-01H2O Health Outcomes Observatory H2Oparticipant10.476.68723
2020-09-01Prioritisation and Risk Evaluation of Medicines in the EnviRonment PREMIERparticipant4.550.00025
2020-05-01Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA INNODIA HARVESTparticipant5.999.05541
2020-01-01Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies ImmUniverseparticipant15.500.00027
2019-12-01Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies imSAVARparticipant10.999.31628
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLparticipant12.004.95337
2019-11-01Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases IDEA-FASTparticipant20.997.52347
2019-09-01Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions 3TRparticipant40.273.19270
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99833
2019-04-01Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation ConcePTIONparticipant15.299.99153
2019-04-01Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement MOBILISE-Dparticipant25.395.89735
2019-04-01Biomarkers in Atopic Dermatitis and Psoriasis BIOMAPparticipant10.500.00032
2019-03-01CARdiomyopathy in type 2 DIAbetes mellitus CARDIATEAMparticipant6.700.00021
2019-03-01Neurotoxicity De-Risking in Preclinical Drug Discovery NeuroDeRiskparticipant5.331.00018
2019-03-01Efficiently Networking European Neurodegeneration Research NEURONETparticipant1.199.12510
2019-03-01Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts IMMUcanparticipant17.830.00028
2019-02-01Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease TransBioLineparticipant13.999.99829
2019-01-01Vaccines and Infectious Diseases in the Ageing PopuLation VITALparticipant5.499.88224
2019-01-01Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain IM2PACTparticipant9.000.00027

Alias institution names:

  • SANOFIAVENTIS